These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination. Redeker A; Arens R Front Immunol; 2016; 7():345. PubMed ID: 27656185 [TBL] [Abstract][Full Text] [Related]
66. T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients. Klaver Y; van Steenbergen SC; Sleijfer S; Debets R; Lamers CH Front Immunol; 2016; 7():648. PubMed ID: 28082983 [TBL] [Abstract][Full Text] [Related]
67. T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy. Bhatta R; Han J; Liu Y; Bo Y; Wang H Biomaterials; 2023 Feb; 293():121972. PubMed ID: 36566554 [TBL] [Abstract][Full Text] [Related]
68. Adoptive T cell therapy: Addressing challenges in cancer immunotherapy. Yee C J Transl Med; 2005 Apr; 3(1):17. PubMed ID: 15860133 [TBL] [Abstract][Full Text] [Related]
69. Dendritic cell-mimicking scaffolds for ex vivo T cell expansion. Kim HS; Ho TC; Willner MJ; Becker MW; Kim HW; Leong KW Bioact Mater; 2023 Mar; 21():241-252. PubMed ID: 36157246 [TBL] [Abstract][Full Text] [Related]
70. Efficient lentiviral transduction method to gene modify cord blood CD8 Lo Presti V; Cornel AM; Plantinga M; Dünnebach E; Kuball J; Boelens JJ; Nierkens S; van Til NP Mol Ther Methods Clin Dev; 2021 Jun; 21():357-368. PubMed ID: 33898633 [TBL] [Abstract][Full Text] [Related]
71. Protocol for generation of human peptide-specific primary CD8 Grant EJ; Gras S STAR Protoc; 2022 Sep; 3(3):101590. PubMed ID: 35942343 [TBL] [Abstract][Full Text] [Related]
72. Beyond the antigen receptor: editing the genome of T-cells for cancer adoptive cellular therapies. Lloyd A; Vickery ON; Laugel B Front Immunol; 2013; 4():221. PubMed ID: 23935598 [TBL] [Abstract][Full Text] [Related]
74. Artificial 3D Culture Systems for T Cell Expansion. Pérez Del Río E; Martinez Miguel M; Veciana J; Ratera I; Guasch J ACS Omega; 2018 May; 3(5):5273-5280. PubMed ID: 30023914 [TBL] [Abstract][Full Text] [Related]
75. Biosprayed spleen cells integrate and function in mouse models. Carter NA; Jayasinghe SN; Mauri C Analyst; 2011 Sep; 136(17):3434-7. PubMed ID: 21451871 [TBL] [Abstract][Full Text] [Related]
76. Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions. Sudarsanam H; Buhmann R; Henschler R Front Bioeng Biotechnol; 2022; 10():886637. PubMed ID: 35845425 [No Abstract] [Full Text] [Related]
78. Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapy. Zhang Z; Liu Q; Tan J; Zhan X; Liu T; Wang Y; Lu G; Wu M; Zhang Y Acta Pharm Sin B; 2021 Jul; 11(7):1965-1977. PubMed ID: 34386331 [TBL] [Abstract][Full Text] [Related]
79. Autolymphocyte therapy-1. In vivo tumor-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes. Eur J Cancer; 1998 May; 34(6):946. PubMed ID: 9840962 [No Abstract] [Full Text] [Related]
80. Optimization manufacture of virus- and tumor-specific T cells. Lapteva N; Vera JF Stem Cells Int; 2011; 2011():434392. PubMed ID: 21915183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]